Chloe McGann is a High School Laboratory Technician in the Tian Lab at the Max Planck Florida Institute for Neuroscience. Her research focuses on using biosensors to study dopamine depletion and alpha-synuclein aggregation, both of which are key factors in the progression of Parkinson’s Disease. Chloe is particularly interested in understanding how these mechanisms contribute to neurodegenerative diseases as a whole, with the ultimate goal of identifying new therapeutic targets. She is passionate about exploring the intricate complexities of the brain and its systems, and is deeply committed to contributing to the development of treatments that can improve the lives of patients suffering from Parkinson’s and other neurological disorders. In her role, Chloe is driven by the potential for discovery and the opportunity to help advance medical research that may one day lead to breakthrough therapies. Outside the lab, Chloe enjoys reading, spending time with family, and being an active member of her church community.